| Dr Parisa Samimi, MD | |
|
201 Park St, Bowling Green, KY 42101-1708 | |
| (270) 783-0452 | |
| (270) 780-0466 |
| Full Name | Dr Parisa Samimi |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 201 Park St, Bowling Green, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003369752 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Parisa Samimi, MD 201 Park St, Bowling Green, KY 42101-1708 Ph: (270) 783-0452 | Dr Parisa Samimi, MD 201 Park St, Bowling Green, KY 42101-1708 Ph: (270) 783-0452 |
News Archive
Central to the study is FXO6, a peptide developed and patented by Austro-American company Fibrex Medical. Fibrex will now test the tolerability and pharmacokinetics of FX06 in humans. The peptide reduces inflammatory responses of the heart muscle that can arise after treatment for a myocardial infarction. Tests will begin immediately on the first - healthy - subjects at the Vienna General Hospital.
Scientists from The Scripps Research Institute (TSRI) and the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have found a way to induce antibodies to fight a wide range of influenza subtypes—work that could one day eliminate the need for repeated seasonal flu shots.
After more than a decade of short-term cures to erectile dysfunction, most aimed at symptoms rather than the underlying issues of nerve damage, a new approach has emerged from adult stem cell technology developed by RNL Bio. Dr. Ji Youl Lee and the RNL Stem Cell Technology Institute (RNL SCTI) team, working at St. Mary's Hospital in Seoul, found in animal studies that adipose (fat) derived adult human stem cells, grown in culture, were very effective in treating cavernous nerve injury.
Ligand Pharmaceuticals Incorporated announced today that its research collaboration with Pfizer for JAK3 has been extended by one year. The Research and License Agreement entered into in December 2006 with Wyeth provided for an initial three year research term. Under this extension, Ligand will receive $3.1 million in research payments to continue conducting drug discovery and lead candidate optimization.
› Verified 4 days ago
Dr. Benjamin Aaron Banasiewicz, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 523 Park St, Bowling Green, KY 42101 Phone: 270-781-0075 Fax: 270-796-2250 | |
Jeffery W. Nemec, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 350 Park St, Suite 203, Bowling Green, KY 42101 Phone: 270-781-0075 Fax: 270-781-0143 | |
Dr. Shebna Unes Kunju, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 523 Park St, Bowling Green, KY 42101 Phone: 270-781-0075 Fax: 270-796-2250 | |
Devin G. Trevor, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 350 Park St, Suite 203, Bowling Green, KY 42101 Phone: 270-781-0075 Fax: 270-781-0143 | |
Dr. Sara L. Mangold, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Park St, Bowling Green, KY 42101 Phone: 270-781-5111 Fax: 270-780-0498 | |
Angela D. Yates, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 Park St, Bowling Green, KY 42101 Phone: 270-780-0562 Fax: 270-780-0466 |